Contents
Current Cancer Drug Targets, Volume 7 - Number 7
Pathobiology of Head and Neck Squamous Tumorigenesis
, 7(7): 606 - 612Adel K. El-Naggar
DOI: 10.2174/156800907782418338
Current Status and Future Perspectives of Chemoprevention in Head and Neck Cancer
, 7(7): 623 - 632Carmen M. Klass and Dong M. Shin
DOI: 10.2174/156800907782418347
Anti-Tumor Vaccines in Head and Neck Cancer: Targeting Immune Responses to the Tumor
, 7(7): 633 - 642Theresa L. Whiteside
DOI: 10.2174/156800907782418310
Targeting Angiogenesis in Head and Neck Cancer
, 7(7): 643 - 649Nabil F. Saba, Dong M. Shin and Fadlo R. Khuri
DOI: 10.2174/156800907782418356
EGFR-Targeting Monoclonal Antibodies in Head and Neck Cancer
, 7(7): 650 - 665Igor Astsaturov, Roger B. Cohen and Paul Harari
DOI: 10.2174/156800907782418365
Recent Advances in Combined Modality Therapy for Locally Advanced Head and Neck Cancer
, 7(7): 674 - 680Lori J. Wirth and Marshall R. Posner
DOI: 10.2174/156800907782418329
Recent Approaches in Chemoprevention of Prostate Cancer
, 7(7): 681 - 688Charles Y.F. Young
DOI: 10.2174/156800907782418284
Targeting MDM2 and MDMX in Retinoblastoma
, 7(7): 689 - 695Nikia A. Laurie, Chie Schin-Shih and Michael A. Dyer
DOI: 10.2174/156800907782418266
Webmaster Contact: info@benthamscience.org